6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
HF outcomes in HFrEF ... on GDMT, with or ... HF outcomes in HFrEF ... SGLT2 #inhibitors #EBM ... #table #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... #CHF #Congestive ... #HeartFailure #
Heart Failure with Preserved Ejection Fraction: Management Principles

General Therapeutic Principles:
Reduce the congestive state 
 - Caution
Principles: Reduce the congestive ... hypertension, pulmonary ... #Cardiology #HFpEF ... dCHF #Diastolic #Treatment ... #HeartFailure #
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
functional ID) Treatment ... mortality and CV ... deficiency #CHF #HFrEF ... #heartfailure # ... diagnosis #management
Severe Heart Failure & Cardiogenic Shock - Management Checklist 
Evaluation 
 - EKG & echocardiography
another option in HFrEF ... milrinone) for HFrEF ... With chronic AF, HFrEF ... Revascularization, treatment ... #Cardiogenic #HeartFailure
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
auscultation, JVD ... with presence of pulmonary ... differential #algorithm #management ... #table #foamed ... #heartfailure #chf